JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,553,000 | +50.1% | 56,900 | 0.0% | 0.09% | +44.4% |
| Q2 2017 | $1,701,000 | +34.7% | 56,900 | 0.0% | 0.06% | +28.6% |
| Q1 2017 | $1,263,000 | +17.7% | 56,900 | 0.0% | 0.05% | +6.5% |
| Q4 2016 | $1,073,000 | -80.4% | 56,900 | -68.7% | 0.05% | -78.1% |
| Q3 2016 | $5,462,000 | -21.9% | 182,000 | 0.0% | 0.21% | -26.6% |
| Q2 2016 | $6,996,000 | +0.9% | 182,000 | 0.0% | 0.29% | -3.1% |
| Q1 2016 | $6,932,000 | -13.4% | 182,000 | 0.0% | 0.30% | +1.7% |
| Q4 2015 | $8,003,000 | +8.1% | 182,000 | 0.0% | 0.29% | +9.0% |
| Q3 2015 | $7,406,000 | – | 182,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|